Clinical Trial - Pembrolizumab - Advanced Bladder Cancr

The clinical trial is run by National Cancer Institute to apply Pembrolizumab in treating locally advanced bladder cancer.

Trial Name: Pembrolizumab in Treating Patients with Locally Advanced Bladder Cancer

Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 407 locations

Pembrolizumab, trade name KEYTRUDA, is a medicine that may treat certain cancers by working with your immune system.

Please find details on

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.